# EDGAR Filing Document

**Accession Number:** 0002124944
**File Stem:** 0001628280-26-033804
**Filing Date:** 2026-5
**Character Count:** 11075
**Document Hash:** f0c04b2200b72ed31bbc7189ac34f58a
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001628280-26-033804.hdr.sgml**: 20260511

**ACCESSION NUMBER**: 0001628280-26-033804

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20260130

**FILED AS OF DATE**: 20260511

**DATE AS OF CHANGE**: 20260511

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Curnes Nelson Bunker
- **CENTRAL INDEX KEY:** 0002124944

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-43275
- **FILM NUMBER:** 26965407

**MAIL ADDRESS:**
- **STREET 1:** 2802 FLINTROCK TRACE, SUITE 226
- **CITY:** AUSTIN
- **STATE:** TX
- **ZIP:** 78738
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Mobia Medical, Inc.
- **CENTRAL INDEX KEY:** 0001489993
- **STANDARD INDUSTRIAL CLASSIFICATION:** SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 208573833
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 2802 FLINTROCK TRACE, SUITE 226
- **CITY:** AUSTIN
- **STATE:** TX
- **ZIP:** 78738
- **BUSINESS PHONE:** (855) 628-9375

**MAIL ADDRESS:**
- **STREET 1:** 2802 FLINTROCK TRACE, SUITE 226
- **CITY:** AUSTIN
- **STATE:** TX
- **ZIP:** 78738

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** MicroTransponder, Inc.
- **DATE OF NAME CHANGE:** 20100420

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Curnes Nelson Bunker<br><sub>(Last) (First) (Middle)</sub><br>2802 FLINTROCK TRACE, SUITE 226<br><sub>(Street)</sub><br>AUSTIN, TX 78738<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2026-01-30 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [ ] 10% Owner<br>[X] Officer (give title below) [ ] Other (specify below)<br>_Chief Financial Officer_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>Mobia Medical, Inc. [ MOBI ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Common Stock | 2026-05-11 |  | C |  | 283895 | A | <sup>(1)</sup> | 303322 | D |  |
| Common Stock | 2026-05-11 |  | X |  | 13684 | A | $14.653 | 317006 | D |  |
| Common Stock | 2026-05-11 |  | F |  | 13368 | D | $15 | 303638 | D |  |
| Common Stock | 2026-05-11 |  | C |  | 5742 | A | <sup>(1)</sup> | 5742 | I | By Family Trusts |
| Common Stock | 2026-05-11 |  | C |  | 476485 | A | <sup>(1)</sup> | 476485 | I | By Exceller Hunt Microtransponder 2017, LP |
| Common Stock | 2026-05-11 |  | C |  | 333333 | A | <sup>(2)</sup> | 809818 | I | By Exceller Hunt Microtransponder 2017, LP |
| Common Stock | 2026-05-11 |  | C |  | 175077 | A | <sup>(2)</sup> | 175077 | I | By Curnes Fund 2001 |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| Convertible Notes | <sup>(2)</sup> | 2026-01-30<sup>(3)</sup> |  | A |  | 2000000 |  | <sup>(2)</sup> | <sup>(2)</sup> | Common Stock | 166666 | $2000000 | 2000000 | I | By Curnes Fund 2001 |
| Convertible Notes | <sup>(2)</sup> | 2026-01-30<sup>(3)</sup> |  | A |  | 4000000 |  | <sup>(2)</sup> | <sup>(2)</sup> | Common Stock | 333333 | $4000000 | 4000000 | I | By Exceller Hunt Microtransponder 2017, LP |
| Convertible Notes | <sup>(2)</sup> | 2026-02-05<sup>(3)</sup> |  | A |  | 100937.62 |  | <sup>(2)</sup> | <sup>(2)</sup> | Common Stock | 8411 | $100937.62 | 2100937.62 | I | By Curnes Fund 2001 |
| Stock Option | $15 | 2026-05-07 |  | A |  | 206070 |  | <sup>(4)</sup> | 2036-05-07 | Common Stock | 206070 | $0 | 206070 | D |  |
| Series A Preferred Stock | <sup>(1)</sup> | 2026-05-11 |  | C |  |  | 191330 | <sup>(1)</sup> | <sup>(1)</sup> | Common Stock | 54932 | <sup>(1)</sup> | 0 | D |  |
| Series C Preferred Stock | <sup>(1)</sup> | 2026-05-11 |  | C |  |  | 100000 | <sup>(1)</sup> | <sup>(1)</sup> | Common Stock | 28710 | <sup>(1)</sup> | 0 | D |  |
| Series D Preferred Stock | <sup>(1)</sup> | 2026-05-11 |  | C |  |  | 383333 | <sup>(1)</sup> | <sup>(1)</sup> | Common Stock | 110058 | <sup>(1)</sup> | 0 | D |  |
| Series E-1 Preferred Stock | <sup>(1)</sup> | 2026-05-11 |  | C |  |  | 29168 | <sup>(1)</sup> | <sup>(1)</sup> | Common Stock | 8374 | <sup>(1)</sup> | 0 | D |  |
| Series F Preferred Stock | <sup>(1)</sup> | 2026-05-11 |  | C |  |  | 284986 | <sup>(1)</sup> | <sup>(1)</sup> | Common Stock | 81821 | <sup>(1)</sup> | 0 | D |  |
| Series C Preferred Stock | <sup>(1)</sup> | 2026-05-11 |  | C |  |  | 20000 | <sup>(1)</sup> | <sup>(1)</sup> | Common Stock | 5742 | <sup>(1)</sup> | 0 | I | By Family Trusts |
| Series D Preferred Stock | <sup>(1)</sup> | 2026-05-11 |  | C |  |  | 505269 | <sup>(1)</sup> | <sup>(1)</sup> | Common Stock | 145067 | <sup>(1)</sup> | 0 | I | By Exceller Hunt Microtransponder 2017, LP |
| Series E-1 Preferred Stock | <sup>(1)</sup> | 2026-05-11 |  | C |  |  | 272271 | <sup>(1)</sup> | <sup>(1)</sup> | Common Stock | 78171 | <sup>(1)</sup> | 0 | I | By Exceller Hunt Microtransponder 2017, LP |
| Series E-2 Preferred Stock | <sup>(1)</sup> | 2026-05-11 |  | C |  |  | 596219 | <sup>(1)</sup> | <sup>(1)</sup> | Common Stock | 171179 | <sup>(1)</sup> | 0 | I | By Exceller Hunt Microtransponder 2017, LP |
| Series F Preferred Stock | <sup>(1)</sup> | 2026-05-11 |  | C |  |  | 285846 | <sup>(1)</sup> | <sup>(1)</sup> | Common Stock | 82068 | <sup>(1)</sup> | 0 | I | By Exceller Hunt Microtransponder 2017, LP |
| Warrants | $14.653 | 2026-05-11 |  | X |  |  | 23666 | <sup>(5)</sup> | 2033-06-13 | Common Stock | 6890 | <sup>(5)</sup> | 0 | D |  |
| Warrants | $14.653 | 2026-05-11 |  | X |  |  | 24000 | <sup>(5)</sup> | 2033-05-24 | Common Stock | 6794 | <sup>(5)</sup> | 0 | D |  |
| Convertible Notes | <sup>(2)</sup> | 2026-05-11 |  | C |  |  | 2100937.62 | <sup>(2)</sup> | <sup>(2)</sup> | Common Stock | 175077 | <sup>(2)</sup> | 0 | I | By Curnes Fund 2001 |
| Convertible Notes | <sup>(2)</sup> | 2026-05-11 |  | C |  |  | 4000000 | <sup>(2)</sup> | <sup>(2)</sup> | Common Stock | 333333 | <sup>(2)</sup> | 0 | I | By Exceller Hunt Microtransponder 2017, LP |

---

### Footnotes:

(1) Each share of the Series A, Series C, Series D, Series E-1, Series E-2 and Series F Preferred Stock converted into Common Stock immediately prior to the completion of the Issuer's initial public offering (the "Offering") pursuant to its terms.

(2) The Convertible Notes automatically converted into Common Stock immediately prior to the closing of the Offering. The conversion price is the lower of (a) 80% of the Offering price per share and (b) the valuation of the Issuer immediately prior to the closing of the Offering divided by the number of fully diluted shares of capital stock (on an as-converted basis) outstanding immediately prior to Offering, excluding the Convertible Notes.

(3) This transaction occurred prior to the Issuer's registration of a class of equity securities under Section 12 of the Securities Exchange Act of 1934, as amended, in connection with the Offering, and is reported herein pursuant to Rule 16a-2(a).

(4) The stock option will vest as to 25% of the underlying shares on May 7, 2027, and will vest thereafter in 36 substantially equal monthly installments.

(5) The warrants are currently exercisable. In connection with the Offering, the warrants were exercised according to the terms of the applicable warrant agreement. The warrants have a net exercise provision under which the Reporting Person may, in lieu of payment of the exercise price in cash, surrender the warrants and receive a net amount of shares based on the fair market value of the shares at the time of exercise of the warrants after deduction of the aggregate exercise price.

**Signature:** /s/ Chase Leavitt, Attorney-in-Fact  
**Date:** 2026-05-11

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**